BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pascher A, Klupp J, Neuhaus P. Endocrine tumours of the gastrointestinal tract. Transplantation in the management of metastatic endocrine tumours. Best Pract Res Clin Gastroenterol. 2005;19:637-648. [PMID: 16183532 DOI: 10.1016/j.bpg.2005.03.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Fendrich V, Bartsch DK. Surgical treatment of gastrointestinal neuroendocrine tumors. Langenbecks Arch Surg. 2011;396:299-311. [PMID: 21279821 DOI: 10.1007/s00423-011-0741-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
2 Ellison EC, Johnson JA. The Zollinger-Ellison syndrome: a comprehensive review of historical, scientific, and clinical considerations. Curr Probl Surg. 2009;46:13-106. [PMID: 19059523 DOI: 10.1067/j.cpsurg.2008.09.001] [Cited by in Crossref: 58] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
3 Åkerström G, Norlén O, Edfeldt K, Crona J, Björklund P, Westin G, Hellman P, Stålberg P. A review on management discussions of small intestinal neuroendocrine tumors ‘midgut carcinoids’. International Journal of Endocrine Oncology 2015;2:119-28. [DOI: 10.2217/ije.15.2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Hori T, Takaori K, Uemoto S. Pancreatic neuroendocrine tumor accompanied with multiple liver metastases. World J Hepatol 2014; 6(8): 596-600 [PMID: 25232452 DOI: 10.4254/wjh.v6.i8.596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
5 Dumlu EG, Karakoç D, Özdemir A. Nonfunctional Pancreatic Neuroendocrine Tumors: Advances in Diagnosis, Management, and Controversies. Int Surg 2015;100:1089-97. [PMID: 25590518 DOI: 10.9738/INTSURG-D-14-00204.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
6 Rossi RE, Burroughs AK, Caplin ME. Liver transplantation for unresectable neuroendocrine tumor liver metastases. Ann Surg Oncol. 2014;21:2398-2405. [PMID: 24562931 DOI: 10.1245/s10434-014-3523-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
7 Bösch F, Hofmann K, Coenen M, Pratschke S, Thomas M, Knösel T, Bruns CJ, Guba M, Werner J, Angele MK. Surgical treatment of pNET - Experience of a "high-volume" center. Surg Oncol 2018;27:409-14. [PMID: 30217295 DOI: 10.1016/j.suronc.2018.05.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
8 D’Haese JG, Tosolini C, Ceyhan GO, Kong B, Esposito I, Michalski CW, Kleeff J. Update on surgical treatment of pancreatic neuroendocrine neoplasms. World J Gastroenterol 2014; 20(38): 13893-13898 [PMID: 25320524 DOI: 10.3748/wjg.v20.i38.13893] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
9 Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 2008;135:1469-92. [PMID: 18703061 DOI: 10.1053/j.gastro.2008.05.047] [Cited by in Crossref: 479] [Cited by in F6Publishing: 382] [Article Influence: 36.8] [Reference Citation Analysis]
10 Le Treut YP, Grégoire E, Belghiti J, Boillot O, Soubrane O, Mantion G, Cherqui D, Castaing D, Ruszniewski P, Wolf P. Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant. 2008;8:1205-1213. [PMID: 18444921 DOI: 10.1111/j.1600-6143.2008.02233.x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 83] [Article Influence: 9.0] [Reference Citation Analysis]
11 Ito T, Igarashi H, Jensen RT. Zollinger-Ellison syndrome: Recent advances and controversies. Curr Opin Gastroenterol. 2013;29:650-661. [PMID: 24100728 DOI: 10.1097/mog.0b013e328365efb1] [Cited by in Crossref: 46] [Cited by in F6Publishing: 21] [Article Influence: 6.6] [Reference Citation Analysis]
12 Fendrich V, Waldmann J, Bartsch DK, Langer P. Surgical management of pancreatic endocrine tumors. Nat Rev Clin Oncol 2009;6:419-28. [DOI: 10.1038/nrclinonc.2009.82] [Cited by in Crossref: 81] [Cited by in F6Publishing: 61] [Article Influence: 6.8] [Reference Citation Analysis]
13 Ehehalt F, Saeger HD, Schmidt CM, Grützmann R. Neuroendocrine tumors of the pancreas. Oncologist. 2009;14:456-467. [PMID: 19411317 DOI: 10.1634/theoncologist.2008-0259] [Cited by in Crossref: 149] [Cited by in F6Publishing: 113] [Article Influence: 12.4] [Reference Citation Analysis]
14 Goldin SB, Aston J, Wahi MM. Sporadically occurring functional pancreatic endocrine tumors: review of recent literature. Curr Opin Oncol 2008;20:25-33. [PMID: 18043253 DOI: 10.1097/CCO.0b013e3282f290af] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ito T, Igarashi H, Jensen RT. Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances. J Gastroenterol. 2012;47:941-960. [PMID: 22886480 DOI: 10.1007/s00535-012-0642-8] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 7.7] [Reference Citation Analysis]
16 Alekseev D, Goralczyk A, Lorf T, Ramadori G, Obed A. Ten years survival with excellent outcome after living donor liver transplantation from 70 years old donor for primary hepatic neuroendocrine carcinoma: Case report. Int J Surg Case Rep. 2012;3:34-36. [PMID: 22288038 DOI: 10.1016/j.ijscr.2011.08.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
17 Alistar A, Sung M, Kim M, Holcombe RF. Clinical pathways for pancreatic neuroendocrine tumors. J Gastrointest Cancer 2012;43:532-40. [PMID: 22661335 DOI: 10.1007/s12029-012-9397-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
18 Barbier L, Neuzillet C, Dokmak S, Sauvanet A, Ruszniewski P, Belghiti J. Liver transplantation for metastatic neuroendocrine tumors. Hepat Oncol 2014;1:409-21. [PMID: 30190976 DOI: 10.2217/hep.14.21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Falconi M, Bartsch DK, Eriksson B, Klöppel G, Lopes JM, O'connor JM, Salazar R, Taal BG, Vullierme MP, O'toole D. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors. Neuroendocrinology 2012;95:120-34. [DOI: 10.1159/000335587] [Cited by in Crossref: 326] [Cited by in F6Publishing: 255] [Article Influence: 36.2] [Reference Citation Analysis]
20 Fendrich V, Michl P, Habbe N, Bartsch DK. Liver-specific therapies for metastases of neuroendocrine pancreatic tumors. World J Hepatol 2010; 2(10): 367-373 [PMID: 21160945 DOI: 10.4254/wjh.v2.i10.367] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
21 Hung JS, Chang MC, Lee PH, Tien YW. Is surgery indicated for patients with symptomatic nonfunctioning pancreatic neuroendocrine tumor and unresectable hepatic metastases? World J Surg. 2007;31:2392-2397. [PMID: 17960455 DOI: 10.1007/s00268-007-9264-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
22 Kulke MH, Anthony LB, Bushnell DL, de Herder WW, Goldsmith SJ, Klimstra DS, Marx SJ, Pasieka JL, Pommier RF, Yao JC, Jensen RT; North American Neuroendocrine Tumor Society (NANETS). NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas. 2010;39:735-752. [PMID: 20664472 DOI: 10.1097/mpa.0b013e3181ebb168] [Cited by in Crossref: 351] [Cited by in F6Publishing: 133] [Article Influence: 35.1] [Reference Citation Analysis]
23 Zhao YP, Zhan HX, Zhang TP, Cong L, Dai MH, Liao Q, Cai LX. Surgical management of patients with insulinomas: Result of 292 cases in a single institution. J Surg Oncol. 2011;103:169-174. [PMID: 21259252 DOI: 10.1002/jso.21773] [Cited by in Crossref: 83] [Cited by in F6Publishing: 60] [Article Influence: 7.5] [Reference Citation Analysis]
24 Pavel M, Baudin E, Couvelard A, Krenning E, Öberg K, Steinmüller T, Anlauf M, Wiedenmann B, Salazar R; Barcelona Consensus Conference participants. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 2012;95:157-176. [PMID: 22262022 DOI: 10.1159/000335597] [Cited by in Crossref: 525] [Cited by in F6Publishing: 416] [Article Influence: 58.3] [Reference Citation Analysis]
25 Moris D, Tsilimigras DI, Ntanasis-stathopoulos I, Beal EW, Felekouras E, Vernadakis S, Fung JJ, Pawlik TM. Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review. Surgery 2017;162:525-36. [DOI: 10.1016/j.surg.2017.05.006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 13.3] [Reference Citation Analysis]
26 Jensen RT, Norton JA. Endocrine Tumors of the Pancreas and Gastrointestinal Tract. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 491-522.e7. [DOI: 10.1016/b978-1-4160-6189-2.00032-9] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
27 Falconi M, Plockinger U, Kwekkeboom DJ, Manfredi R, Korner M, Kvols L, Pape UF, Ricke J, Goretzki PE, Wildi S. Well-differentiated pancreatic nonfunctioning tumors/carcinoma. Neuroendocrinology. 2006;84:196-211. [PMID: 17312380 DOI: 10.1159/000098012] [Cited by in Crossref: 179] [Cited by in F6Publishing: 141] [Article Influence: 12.8] [Reference Citation Analysis]
28 Jensen RT, Niederle B, Mitry E, Ramage JK, Steinmuller T, Lewington V, Scarpa A, Sundin A, Perren A, Gross D, O'Connor JM, Pauwels S, Kloppel G;  Frascati Consensus Conference;  European Neuroendocrine Tumor Society. Gastrinoma (duodenal and pancreatic). Neuroendocrinology. 2006;84:173-182. [PMID: 17312377 DOI: 10.1159/000098009] [Cited by in Crossref: 182] [Cited by in F6Publishing: 130] [Article Influence: 13.0] [Reference Citation Analysis]
29 Machairas N, Daskalakis K, Felekouras E, Alexandraki KI, Kaltsas G, Sotiropoulos GC. Currently available treatment options for neuroendocrine liver metastases. Ann Gastroenterol 2021;34:130-41. [PMID: 33654350 DOI: 10.20524/aog.2021.0574] [Reference Citation Analysis]
30 Dhupar R, de Vera ME, Marsh JW, Fontes PA, Steel JL, Zeh HJ, Gamblin TC. Simultaneous pancreatectomy and liver transplantation: a single-institution experience. HPB (Oxford) 2009;11:242-6. [PMID: 19590654 DOI: 10.1111/j.1477-2574.2009.00043.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
31 Le Treut YP, Gregoire E, Klempnauer J, Belghiti J, Jouve E, Lerut J, Castaing D, Soubrane O, Boillot O, Mantion G, Homayounfar K, Bustamante M, Azoulay D, Wolf P, Krawczyk M, Pascher A, Suc B, Chiche L, de Urbina JO, Mejzlik V, Pascual M, Lodge JP, Gruttadauria S, Paye F, Pruvot FR, Thorban S, Foss A, Adam R, For ELITA. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: A 213-case European liver transplant registry study. Ann Surg. 2013;257:807-815. [PMID: 23532105 DOI: 10.1097/sla.0b013e31828ee17c] [Cited by in Crossref: 127] [Cited by in F6Publishing: 44] [Article Influence: 15.9] [Reference Citation Analysis]